Skip to content

Randomized multicenter prospective clinical observation for clotrimazole vaginal cream in the treatment of vulvovaginal candidiasis

Randomized multicenter prospective clinical observation for clotrimazole vaginal cream in the treatment of vulvovaginal candidiasis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023005
Enrollment
Unknown
Registered
2019-05-06
Start date
2016-06-06
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulvovaginal Candidiasis

Interventions

Group 2:Clotrimazole Cream
Group 1:Clotrimazole Tablets

Sponsors

Beijing Xiehe Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years old; 2. Vaginal secretion fungal test positive (Find pseudomycelia and buds by microscopic examination); 3. Vulvar and vaginal severe pruritus, thick curdy vaginal discharge, bean dregs or cheese-like; 4. Severe VVC with at least 1 vaginal secretion fungal culture result.

Exclusion criteria

Exclusion criteria: 1. Vulvovaginitis caused by other causes of infection such as trichomonas vaginitis or suspected gonorrhea, genital warts and other diseases; 2. Pregnancy(If necessary, according to blood G-HCG) or Lactating woman; 3. Liver and kidney dysfunction, application of immunosuppressive agents, blood diseases, diabetes, psychosis or other diseases; 4. Poor compliance.

Design outcomes

Primary

MeasureTime frame
VVC scores;Fungus;

Secondary

MeasureTime frame
Vaginal secretion culture;

Countries

China

Contacts

Public ContactShi Honghui

Beijing Xiehe Hospital, Chinese Academy of Medical Sciences

honghuishi@sina.com+86 15711129505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026